| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $47.9B | $47.1B | $45.8B | $43.0B | $38.7B | $33.0B | $37.3B | $31.9B |
| Cost of Revenue | $18.4B | $18.3B | $18.5B | $18.0B | $15.4B | $13.4B | $14.6B | $11.8B |
| Gross Profit | $29.5B | $28.7B | $27.2B | $25.0B | $23.3B | $19.6B | $22.6B | $20.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $14.5B | $14.6B | $14.0B | $12.9B | $12.1B | $9.7B | $12.1B | $10.3B |
| Operating Income | $13.8B | $10.0B | $11.3B | $10.9B | $10.3B | $9.0B | $10.1B | $8.7B |
| Net Income | $13.1B | $10.6B | $10.7B | $9.5B | $9.8B | $7.7B | $8.9B | $6.4B |
| EPS (Basic) | $3.05 | $2.47 | $2.48 | $2.20 | $2.26 | $1.80 | $2.09 | $1.51 |
| EPS (Diluted) | $3.04 | $2.46 | $2.47 | $2.19 | $2.25 | $1.79 | $2.07 | $1.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $104.8B | $100.5B | $97.7B | $92.8B | $94.4B | $87.3B | $86.4B | $83.2B |
| Current Assets | $31.0B | $26.0B | $26.7B | $22.6B | $22.5B | $19.2B | $20.4B | $30.6B |
| Cash & Equivalents | $10.3B | $10.8B | $9.4B | $9.5B | $9.7B | $6.8B | $6.5B | $8.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $21.3B | $25.2B | $23.6B | $19.7B | $19.9B | $14.6B | $27.0B | $29.2B |
| Stockholders' Equity | $32.2B | $24.9B | $25.9B | $24.1B | $23.0B | $19.3B | $19.0B | $17.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.4B | $6.8B | $11.6B | $11.0B | $12.6B | $9.8B | $10.5B | $7.3B |
| Investing Cash Flow | $-0.1B | $2.5B | $-3.3B | $-0.8B | $-2.8B | $-1.5B | $-4.0B | $6.3B |
| Capital Expenditures | $2.1B | $2.1B | $1.9B | $1.5B | $1.4B | $1.2B | $2.1B | $1.3B |
| Financing Cash Flow | $-8.1B | $-6.9B | $-8.3B | $-10.3B | $-6.8B | $-8.1B | $-9.0B | $-10.6B |